TREX1 and Aicardi-Goutieres syndrome: Indeed, RT inhibitors are efficacious in IFN-driven systemic inflammation observed in the Trex1-/- (a DNase) mouse model of AGS (143) and reduce the IFN signature in patients with AGS (145).